About a year ago Apple made headlines when the Apple Watch became the first ECG reading wearable to get FDA-clearance. It’s part of a trend for health tracking tech – that now includes this credit-card sized WiWe portable ECG monitor – that’s attempting to make it easier than ever to keep track of your heart health.
These questions have been raised by the manufacturers of other consumer devices, such as WIWE, which I also mentioned in my previous article about the Apple Watch 4. The company has worked for years to produce a device the size of a credit card which works by holding both thumbs on, making sure your hands do not touch, that gives an electrocardiogram with complete data and graphs recording arrhythmia, atrial fibrillation, ventricular heterogeneity and oxygen saturation in the blood stream, and then Apple comes along with a device that provides similar data using… a watch. No wonder WIWE is skeptical.
Handheld 1-lead ECG devices, such as WIWE, can serve as an excellent way for people to routinely monitor their ECG for potential arrhythmias at home and determine if further follow-up with a physician is indicated.